These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23724621

  • 1. Evaluating appropriateness of digoxin, carbamazepine, valproic acid, and phenytoin usage by therapeutic drug monitoring.
    Dalaklioglu S.
    Clin Lab; 2013; 59(3-4):325-31. PubMed ID: 23724621
    [Abstract] [Full Text] [Related]

  • 2. Measuring the appropriateness of carbamazepine and valproic acid prescribing and utilization using a newly implemented online system in the Tabuk Region of Saudi Arabia.
    Al-Balawi RS, Alshehri MA, Alatawi AS, Al Shehri AM, Alshehry MA, Al-Gayyar MMH.
    Saudi Pharm J; 2020 Jul; 28(7):844-849. PubMed ID: 32647486
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine drug interactions in a TDM material.
    Böttiger Y, Svensson JO, Ståhle L.
    Ther Drug Monit; 1999 Apr; 21(2):171-4. PubMed ID: 10217336
    [Abstract] [Full Text] [Related]

  • 4. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs.
    Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D.
    J Med Assoc Thai; 2009 Nov; 92(11):1500-7. PubMed ID: 19938743
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic monitoring of digoxin and antiepileptic drugs in Egypt and Saudi Arabia.
    EL Desoky ES, AL-Ghamdi HA, Halaby FH, Al-Beshri M.
    Ther Drug Monit; 2003 Apr; 25(2):211-4. PubMed ID: 12657916
    [Abstract] [Full Text] [Related]

  • 6. Appropriateness of antiepileptic drug level monitoring.
    Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW.
    JAMA; 2003 Apr; 274(20):1622-6. PubMed ID: 7474249
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ, Molitoris BA, Nakata LM, Gal J.
    Am J Nephrol; 1986 Apr; 6(2):132-4. PubMed ID: 3085501
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G, Malla S, Shakya KN, Shrestha R.
    JNMA J Nepal Med Assoc; 2008 Apr; 47(171):94-7. PubMed ID: 19079370
    [Abstract] [Full Text] [Related]

  • 9. An audit of therapeutic drug monitoring of anticonvulsants.
    Sharpe PC, Morrow J, Trimble ER.
    Ulster Med J; 1995 Oct; 64(2):151-6. PubMed ID: 8533181
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic monitoring of drug concentration in blood. Are the analyses correctly ordered?].
    Ahlers AA, Nielsen C.
    Ugeskr Laeger; 1991 Apr 29; 153(18):1281-4. PubMed ID: 2028544
    [Abstract] [Full Text] [Related]

  • 11. The effect of antiepileptic drugs on re-myelinization of axons: Phenytoin, levetiracetam, carbamazepine, and valproic acid, used following traumatic brain injury.
    Demirci H, Kuzucu P, Seymen CM, Gülbahar Ö, Özişik P, Emmez H.
    Clin Neurol Neurosurg; 2021 Oct 29; 209():106911. PubMed ID: 34509750
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic Drug Monitoring Characteristics in a Tertiary University Hospital in 2019.
    Ozunal ZG, Ongen İpek B.
    Cureus; 2020 Apr 10; 12(4):e7612. PubMed ID: 32399346
    [Abstract] [Full Text] [Related]

  • 13. Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.
    Dasgupta A, Wells A, Chow L.
    Ther Drug Monit; 1999 Aug 10; 21(4):421-5. PubMed ID: 10442696
    [Abstract] [Full Text] [Related]

  • 14. Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury.
    Massagli TL.
    Arch Phys Med Rehabil; 1991 Mar 10; 72(3):219-26. PubMed ID: 1998458
    [Abstract] [Full Text] [Related]

  • 15. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B, Atli O, Ilgin S.
    Hum Exp Toxicol; 2012 Oct 10; 31(10):971-80. PubMed ID: 22588177
    [Abstract] [Full Text] [Related]

  • 16. Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman.
    Al Za'abi M, Al Muqbali J, Al-Waili K.
    Saudi Pharm J; 2015 Sep 10; 23(4):458-62. PubMed ID: 27134551
    [Abstract] [Full Text] [Related]

  • 17. Appropriateness of serum level determinations of antiepileptic drugs.
    Affolter N, Krähenbühl S, Schlienger RG.
    Swiss Med Wkly; 2003 Nov 22; 133(43-44):591-7. PubMed ID: 14745654
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH, Mehla J, Pahuja M, Gupta YK.
    Pharmacol Biochem Behav; 2011 Sep 22; 99(3):399-407. PubMed ID: 21641922
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A, Eslamai MH.
    Int J Clin Pharmacol Ther; 2007 Feb 22; 45(2):121-5. PubMed ID: 17323792
    [Abstract] [Full Text] [Related]

  • 20. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M, Huitema AD, Boogerd W, van der Sande JJ, Schellens JH, Beijnen JH.
    Basic Clin Pharmacol Toxicol; 2006 Aug 22; 99(2):133-40. PubMed ID: 16918714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.